1.1 Articolo in rivista: [36433] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 3.381 a 3.400 di 36.433
Titolo Data di pubblicazione Autore(i) File
Immunotherapy vs Best Supportive Care for Patients with Hepatocellular Cancer with Child-Pugh B Dysfunction 1-gen-2024 Fulgenzi, C. A. M.; Scheiner, B.; D'Alessio, A.; Mehan, A.; Manfredi, G. F.; Celsa, C.; Nishida, N.; Ang, C.; Marron, T. U.; Wu, L.; Saeed, A.; Wietharn, B.; Cammarota, A.; Pressiani, T.; Pinter, M.; Sharma, R.; Cheon, J.; Huang, Y. -H.; Lee, P. -C.; Phen, S.; Gampa, A.; Pillai, A.; Napolitano, A.; Vivaldi, C.; Salani, F.; Masi, G.; Silletta, M.; Lo Prinzi, F.; Di Giacomo, E.; Vincenzi, B.; Bettinger, D.; Thimme, R.; Vogel, A.; Schonlein, M.; Von Felden, J.; Schulze, K.; Wege, H.; Galle, P. R.; Pirisi, M.; Park, J. -W.; Kudo, M.; Rimassa, L.; Singal, A. G.; El Tomb, P.; Ulahannan, S.; Parisi, A.; Chon, H. J.; Hsu, W. -F.; Ghittoni, G.; Camma, C.; Stefanini, B.; Trevisani, F.; Giannini, E. G.; Cortellini, A.; Pinato, D. J.
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis 1-gen-2024 D'Alessio, A.; Stefanini, B.; Blanter, J.; Adegbite, B.; Crowley, F.; Yip, V.; Slater, S.; Fulgenzi, C. A. M.; Celsa, C.; Manfredi, G. F.; Pai, M.; Goldin, R. D.; Ward, S. C.; Fiel, M. I.; Shu, D. H.; Su, Y. -Y.; Cortellini, A.; Baretti, M.; Anders, R.; Yarchoan, M.; Hsu, C.; Marron, T. U.; Pinato, D. J.
Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survival 1-gen-2024 Yang, L.; Murthy, S.; Cortellini, A.; Lim, E. A.; Gonzalez, M.; Pinato, D. J.; Abdel-Malek, M.; Mahmoud, S.; Martin, N. M.
Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy 1-gen-2024 Kennedy, A. S.; Brown, D. B.; Fakih, M.; Jeyarajah, R.; Jones, S.; Liu, D.; Pinato, D. J.; Sangro, B.; Sharma, N. K.; Sze, D. Y.; Van Cutsem, E.; Wasan, H. S.
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease 1-gen-2024 Luke, J. J.; Davar, D.; Andtbacka, R. H.; Bhardwaj, N.; Brody, J. D.; Chesney, J.; Coffin, R.; de Baere, T.; de Gruijl, T. D.; Fury, M.; Goldmacher, G.; Harrington, K. J.; Kaufman, H.; Kelly, C. M.; Khilnani, A. D.; Liu, K.; Loi, S.; Long, G. V.; Melero, I.; Middleton, M.; Neyns, B.; Pinato, D. J.; Sheth, R. A.; Solomon, S. B.; Szapary, P.; Marabelle, A.
Safety and efficacy of itacitinib, a selective JAK1 inhibitor, in advanced hepatocellular cancer: Phase 1b trial (JAKAL) 1-gen-2024 Troiani, A.; Martinez, M.; Ward, C.; Benartzi, C. W.; Pinato, D. J.; Sharma, R.
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer 1-gen-2024 Hedayat, S.; Cascione, L.; Cunningham, D.; Schirripa, M.; Lampis, A.; Hahne, J. C.; Tunariu, N.; Hong, S. P.; Marchetti, S.; Khan, K.; Fontana, E.; Angerilli, V.; Delrieux, M.; Rodrigues, D. N.; Procaccio, L.; Rao, S.; Watkins, D.; Starling, N.; Chau, I.; Braconi, C.; Fotiadis, N.; Begum, R.; Guppy, N.; Howell, L.; Valenti, M.; Cribbes, S.; Kolozsvari, B.; Kirkin, V.; Lonardi, S.; Ghidini, M.; Passalacqua, R.; Elghadi, R.; Magnani, L.; Pinato, D. J.; Di Maggio, F.; Ghelardi, F.; Sottotetti, E.; Vetere, G.; Ciraci, P.; Vlachogiannis, G.; Pietrantonio, F.; Cremolini, C.; Cortellini, A.; Loupakis, F.; Fassan, M.; Valeri, N.
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study 1-gen-2024 Fletcher, K.; Cortellini, A.; Ganta, T.; Kankaria, R.; Song, H.; Ye, F.; Irlmeier, R.; Debnath, N.; Saeed, A.; Radford, M.; Alahmadi, A.; Diamond, A.; Hoimes, C.; Presley, C. J.; Owen, D. H.; Abou Alaiwi, S.; Nassar, A. H.; Lamberti, G.; Perrone, F.; Buti, S.; Giusti, R.; Filetti, M.; Vanella, V.; Mallardo, D.; Sussman, T. A.; Galetta, D.; Kalofonou, F.; Daniels, E.; Ascierto, P. A.; Pinato, D. J.; Nebhan, C.; Berg, S.; Choueiri, T. K.; Marron, T. U.; Wang, Y.; Naqash, A. R.; Johnson, D. B.
Balancing Efficacy and Tolerability of First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis 1-gen-2023 Celsa, C.; Cabibbo, G.; Pinato, D. J.; Di Maria, G.; Enea, M.; Vaccaro, M.; Battaglia, S.; Rizzo, G. E. M.; Giuffrida, P.; Giacchetto, C. M.; Rancatore, G.; Grassini, M. V.; Camma, C.
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study 1-gen-2024 Pinato, D. J.; D'Alessio, A.; Fulgenzi, C. A. M.; Schlaak, A. E.; Celsa, C.; Killmer, S.; Blanco, J. M.; Ward, C.; Stikas, C. -V.; Openshaw, M. R.; Acuti, N.; Nteliopoulos, G.; Balcells, C.; Keun, H. C.; Goldin, R. D.; Ross, P. J.; Cortellini, A.; Thomas, R.; Young, A. -M.; Danckert, N.; Tait, P.; Marchesi, J. R.; Bengsch, B.; Sharma, R.
Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma 1-gen-2024 Salie, H.; Wischer, L.; D'Alessio, A.; Godbole, I.; Suo, Y.; Otto-Mora, P.; Beck, J.; Neumann, O.; Stenzinger, A.; Schirmacher, P.; Fulgenzi, C. A. M.; Blaumeiser, A.; Boerries, M.; Roehlen, N.; Schultheiss, M.; Hofmann, M.; Thimme, R.; Pinato, D. J.; Longerich, T.; Bengsch, B.
Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapy-based systemic therapy 1-gen-2024 Scheiner, B.; Kang, B.; Balcar, L.; Radu, I. -P.; Reiter, F. P.; Adzic, G.; Guo, J.; Gao, X.; Yuan, X.; Cheng, L.; Gorgulho, J.; Schultheiss, M.; Peeters, F.; Hucke, F.; Ben Khaled, N.; Piseddu, I.; Philipp, A.; Sinner, F.; D'Alessio, A.; Pomej, K.; Saborowski, A.; Bathon, M.; Schwacha-Eipper, B.; Zarka, V.; Lampichler, K.; Nishida, N.; Lee, P. -C.; Krall, A.; Saeed, A.; Himmelsbach, V.; Tesini, G.; Huang, Y. -H.; Vivaldi, C.; Masi, G.; Vogel, A.; Schulze, K.; Trauner, M.; Djanani, A.; Stauber, R.; Kudo, M.; Parikh, N. D.; Dufour, J. -F.; Prejac, J.; Geier, A.; Bengsch, B.; von Felden, J.; Venerito, M.; Weinmann, A.; Peck-Radosavljevic, M.; Finkelmeier, F.; Dekervel, J.; Ji, F.; Wang, H. -W.; Rimassa, L.; Pinato, D. J.; Bouattour, M.; Chon, H. J.; Pinter, M.
Circulating tumor DNA dynamics and clinical outcome in metastatic colorectal cancer patients undergoing front-line chemotherapy 1-gen-2024 Ghidini, Michele; Hahne, Jens C; Senti, Chiara; Heide, Timon; Proszek, Paula Z; Shaikh, Ridwan; Carter, Paul; Hubank, Michael; Trevisani, Francesco; Garrone, Ornella; Cappelletti, Maria Rosa; Generali, Daniele; Cattaneo, Monica; Gnocchi, Nicoletta; Donati, Gianvito; Gobbi, Angela; Grizzi, Giulia; Lampis, Andrea; Elghadi, Raghad; Tanzi, Giulia; Tomasello, Gianluca; Ratti, Margherita; Pinato, David J; Fassan, Matteo; Vlachogiannis, Georgios; Sottoriva, Andrea; Passalacqua, Rodolfo; Valeri, Nicola
Prior antibiotics, proton pump inhibitors, and probiotics in patients with extensive stage small cell lung cancer treated with immune checkpoint blockade: A post-hoc analysis of the phase I/III IMpower 133 trial 1-gen-2025 Takada, K.; Takamori, S.; Shimokawa, M.; Pinato, D. J.; Cortellini, A.
Early hepatic decompensation identifies patients with hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab or Sorafenib at highest risk of death 1-gen-2024 Cabibbo, Giuseppe; Celsa, Ciro; Battaglia, Salvatore; Enea, Marco; Di Maria, Gabriele; Grova, Alessandro; Ciccia, Roberta; Manfredi, Giulia F; Iavarone, Massimo; Vogel, Arndt; Singal, Amit G; Reig, Maria; Pinato, David J; Cammà, Calogero
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213) 1-gen-2024 Jin, Z. -C.; Zhou, J. -W.; Chen, J. -J.; Ding, R.; Scheiner, B.; Wang, S. -N.; Li, H. -L.; Shen, Q. -X.; Lu, Q. -Y.; Liu, Y.; Zhang, W. -H.; Luo, B.; Shi, H. -B.; Huang, M.; Wu, Y. -M.; Yuan, C. -W.; Huang, M. -S.; Li, J. -P.; Wu, J. -B.; Zhu, X. -L.; Zhong, B. -Y.; Zhou, H. -F.; Wang, Y. -Q.; Gu, S. -Z.; Peng, Z. -Y.; Zheng, C. -S.; Liu, R. -B.; Xu, G. -H.; Yang, W. -Z.; Xu, A. -B.; Liu, D. -F.; Qi, X.; Yeo, Y.; Zhu, H. -D.; Zhao, Y.; Pinato, D.; Ji, F.; Teng, G. -J.
Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma 1-gen-2024 Cappuyns, Sarah; Piqué-Gili, Marta; Esteban-Fabró, Roger; Philips, Gino; Balaseviciute, Ugne; Pinyol, Roser; Gris-Oliver, Albert; Vandecaveye, Vincent; Abril-Fornaguera, Jordi; Montironi, Carla; Bassaganyas, Laia; Peix, Judit; Zeitlhoefler, Marcus; Mesropian, Agavni; Huguet-Pradell, Júlia; Haber, Philipp K; Figueiredo, Igor; Ioannou, Giorgio; Gonzalez-Kozlova, Edgar; D'Alessio, Antonio; Mohr, Raphael; Meyer, Tim; Lachenmayer, Anja; Marquardt, Jens U; Reeves, Helen L; Edeline, Julien; Finkelmeier, Fabian; Trojan, Jörg; Galle, Peter R; Foerster, Friedrich; Mínguez, Beatriz; Montal, Robert; Gnjatic, Sacha; Pinato, David J; Heikenwalder, Mathias; Verslype, Chris; Van Cutsem, Eric; Lambrechts, Diether; Villanueva, Augusto; Dekervel, Jeroen; Llovet, Josep M
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma 1-gen-2024 Talukder, Rafee; Bakaloudi, Dimitra Rafailia; Makrakis, Dimitrios; Diamantopoulos, Leonidas N; Enright, Thomas; Leary, Jacob B; Raychaudhuri, Ruben; Tripathi, Nishita; Agarwal, Neeraj; Jindal, Tanya; Brown, Jason R; Zakharia, Yousef; Rey-Cárdenas, Macarena; Castellano, Daniel; Nguyen, Charles B; Alva, Ajjai; Zakopoulou, Roubini; Bamias, Aristotelis; Barrera, Rafael Morales; Marmolejo, David; Drakaki, Alexandra; Pinato, David J; Korolewicz, James; Buznego, Lucia Alonso; Duran, Ignacio; Carballeira, Clara Castro; Mckay, Rana R; Stewart, Tyler F; Gupta, Shilpa; Barata, Pedro; Yu, Evan Y; Koshkin, Vadim S; Khaki, Ali Raza; Grivas, Petros
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma 1-gen-2023 Dharmapuri, Sirish; Özbek, Umut; Jethra, Hiren; Jun, Tomi; Marron, Thomas U; Saeed, Anwaar; Huang, Yi-Hsiang; Muzaffar, Mahvish; Pinter, Matthias; Balcar, Lorenz; Fulgenzi, Claudia; Amara, Suneetha; Weinmann, Arndt; Personeni, Nicola; Scheiner, Bernhard; Pressiani, Tiziana; Navaid, Musharraf; Bengsch, Bertram; Paul, Sonal; Khan, Uqba; Bettinger, Dominik; Nishida, Naoshi; Mohamed, Yehia Ibrahim; Vogel, Arndt; Gampa, Anuhya; Korolewicz, James; Cammarota, Antonella; Kaseb, Ahmed; Galle, Peter R; Pillai, Anjana; Wang, Ying-Hong; Cortellini, Alessio; Kudo, Masatoshi; D'Alessio, Antonio; Rimassa, Lorenza; Pinato, David James; Ang, Celina
The Hammersmith Score Optimises Patient Selection and Predicts for Overall Survival in Early-Phase Cancer Trial Participants Independent of Tumour Burden 1-gen-2024 Korolewicz, James Alexander; Scheiner, Bernhard; Fulgenzi, Claudia A M; D'Alessio, Antonio; Cortellini, Alessio; Pascual, Chynna; Mehan, Aman; Partridge, Sarah; Gujral, Dorothy M; Mohammed, Waleed; Mohammed, Oreoluwa; Grzesiak, Aneta; Booker, Lauren; Cleator, Susan; Pokrovska, Tzveta; Saleem, Waqar; Rackie, James; Needham, Yasmine; Krell, Jonathan; Mcneish, Iain; Tookman, Laura; Park, Won-Ho Edward; Asif, Muzamil; Evans, Joanne S; Pinato, David J
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 3.381 a 3.400 di 36.433
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista36432
  • 4 Contributo in Atti di Convegno ...1
Autore
  • ARNEODO, Michele1426
  • ARCIDIACONO, Roberta1411
  • RUSPA, Marta1323
  • GAIDANO, Gianluca771
  • RAMELLO, Luciano702
  • SITTA, Mario650
  • CORTESE, Pietro642
  • SACERDOTE, Carlotta548
  • Patti, Giuseppe Rocco Salvatore429
  • PIRISI, Mario414
Data di pubblicazione
  • In corso di stampa60
  • 2020 - 202710169
  • 2010 - 201913045
  • 2000 - 20097284
  • 1990 - 19994152
  • 1980 - 19891467
  • 1970 - 1979232
  • 1962 - 196924
Rivista
  • PHYSICS LETTERS. SECTION B774
  • JOURNAL OF HIGH ENERGY PHYSICS502
  • PHYSICAL REVIEW LETTERS297
  • THE EUROPEAN PHYSICAL JOURNAL. C,...284
  • PHYSICAL REVIEW D235
  • JOURNAL OF HIGH ENERGY PHYSICS183
  • PLOS ONE182
  • BLOOD169
  • INTERNATIONAL JOURNAL OF MOLECULA...169
  • NUCLEAR INSTRUMENTS & METHODS IN ...145
Keyword
  • Humans1437
  • Female757
  • Male607
  • Middle Aged459
  • Adult415
  • Aged406
  • COVID-19344
  • Italy298
  • Animals217
  • Treatment Outcome196
Lingua
  • eng24950
  • ita5338
  • fre261
  • spa174
  • ger58
  • rus29
  • und26
  • por17
  • lat15
  • grc6
Accesso al fulltext
  • no fulltext21529
  • reserved7320
  • open5109
  • restricted2361
  • partially open90
  • embargoed15
  • mixed9